Season 4

UnitedHealthcare makes a confounding decision that could affect countless patients starting June 1st. Gastroenterologist Dr. Bruce Hennessy joins us to discuss how new prior authorizations for colonoscopies and other screenings could delay cancer...

C. diff, an infectious disease can be deadly for many – but especially those with compromised immune systems. We speak with a member of the Patients Rising team about their run-ins with the disease and learn how you can best …

May marks National Stroke Awareness Month and this week we’re speaking with a stroke survivor who wants to make sure if a stroke ever happens to you – you’ll know all the signs. Hear Stacy Quinn’s personal story and how …

So often on the Patients Rising Podcast, we discuss the affordability of healthcare. This week, guest Peter Kolchinsky outlines how thinking of paying for medicines like paying for a house mortgage leads to lower costs for patients, and encourages...

For many patients living with chronic illness the idea of “fundraising” isn’t just a child’s bakesale to pay for a field trip, it’s a necessity to pay for life-saving treatment. On this week’s podcast we speak with , Director of …

AI is having its moment in all industries, including healthcare. In this episode, hear how AI-driven tools can help oncologists treat patients. , CEO of , talks about the role of AI in care and how it helps doctors do …

The ability to catch cancer early on can greatly improve a patient’s outcome. But most cancers don’t have a . That means many patients may have cancer but not show symptoms until the disease progresses. By then, treatment options may …

Mystery healthcare prices leave patients in the dark. But thanks to hospital and insurer price transparency rules, those costs are being made public. The catch? The files that contain those prices aren’t easy for consumers to read. Health tech...

Get a look at the behind-the-scenes math that often determines whether or not insurance will cover the costs of treatments. Health technology assessments attempt to determine the value of a new treatment. But not all of these equations take into...

is one of the biggest barriers to patient care. But when employers cover transportation for patients, it can lead to better health outcomes and lower overall costs. of explains why employers need to incorporate transportation into their health...

Vertical integration in the vision insurance market has led to higher costs and fewer options for patients. Two optometrists, and , explain how this impacts the price of your glasses, and how the DOC Access Act could fix this problem. …

The Patients Rising Podcast has moved to Monday mornings! In this episode, hear how , the pharmaceutical middlemen, and how potential reforms would help patients access affordable medications. gives his updates from the Sunshine State. ...

Ahead of Rare Disease Day, Congresswoman Cathy McMorris Rodgers (WA-05) joins the podcast to discuss new legislation that would ban the use of a discriminatory health care metric, quality adjusted life year, or QALY. Learn how the QALY hurts...

Current barriers to clinical trial access make it difficult for patients from underserved communities to access cutting edge care. Those barriers include restrictive eligibility criteria, which can lead to an underrepresentation of racial and ethnic...

Stephen Kay took a job 10 hours away from his wife. Why? Because he needed insurance that would cover the costs of her multiple sclerosis care. While she had Medicare before turning 65, she was unable to purchase a supplemental …

Over the past 30 years, cancer death rates have declined by 33%. Ahead of World Cancer Day, hematologist Dr. Rafael Fonseca joins the podcast to talk about the latest innovations and improvements in cancer care delivery that have contributed to …

This year, six biosimilars for the top-selling medicine, Humira, will enter the market, with the first launching on January 31, 2023. Increased competition from biosimilars can drive down costs. But experts argue that insurers and pharmacy benefit...

Can a divided Congress work together to help patients? Health policy experts Jon Deuser and Mike Gaffin tackle that question. They explain what health care issues Congress might address, including the lack of transparency around pharmacy benefit...

A new Alzheimer’s treatment received FDA approval under the accelerated approval program. Former FDA Associate Commissioner Peter Pitts explains how the accelerated approval pathway leads to incremental innovation, or building blocks to develop the...

Last year President Biden signed the Inflation Reduction Act into law, which included several changes to Medicare. Terry and Dr. Bob discuss the three changes that start this year, including the $35 monthly cap on insulin, and more. Hosts: ...